Signed binding term sheet granting Intact Therapeutics an exclusive option to license PCS12852Continue enrolling patients in Phase 2 study of…
July 01, 2025 09:00 ET | Source: Inmagene Biopharmaceuticals The ADAPTIVE Phase 2b trial evaluates multiple dose regimens of IMG-007…
ESTERO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Visory Health, a leading patient-first health tech prescription platform that is transforming…
Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746…
OSE Immunotherapeutics Publishes Letter to Shareholders NANTES, France, June 30, 2025, 6:00 p.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo:…
June 30, 2025 12:00 ET | Source: IBA SA June 30th, 2025 Publication made under article 15 of the…
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces it will once again support select players during high profile matches…
TORONTO, June 27, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX:VHI) (OTCQX:VHIBF) (the “Company” or “VitalHub”) announced today the voting results…
Hapbee Expands Board by Three Members with Senior Leaders in Tech, Legal, and Finance as it Enters Next Phase of…
LOS ANGELES, June 28, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Audien Hearing, a pioneering U.S.-based direct-to-consumer technology company, today…